2024 Q3 Communicable Disease Report
SUMMARY OF SELECT REPORTABLE DISEASES*
|
|
JAN-SEP of the year |
5-year median** |
|
|
MORBIDITY |
2023 |
2024 |
|
|
Campylobacteriosis |
25 |
17 |
44 |
|
Carbapenem-resistant Enterobacteriaceae (CRE) |
7 |
23 |
7 |
|
Chagas disease |
1 |
0 |
0 |
|
Coccidioidomycosis (Valley Fever) |
95 |
129 |
101 |
|
Creutzfeldt-Jakob Disease (CJD) |
1 |
0 |
0 |
|
Cryptosporidiosis |
3 |
1 |
2 |
|
Dengue |
0 |
0 |
0 |
|
E. coli, Shiga toxin-producing |
6 |
2 |
1 |
|
Giardiasis |
5 |
7 |
1 |
|
Haemophilus influenzae, invasive disease |
0 |
0 |
1 |
|
Hepatitis A |
0 |
2 |
2 |
|
Hepatitis B |
17 |
9 |
17 |
|
Influenza |
859 |
1,144 |
842 |
|
Legionellosis |
3 |
2 |
1 |
|
Lyme disease |
1 |
0 |
0 |
|
Malaria |
0 |
0 |
0 |
|
Measles |
0 |
0 |
0 |
|
Meningococcal invasive disease |
0 |
0 |
0 |
|
Mpox (Monkeypox) |
0 |
0 |
0 |
|
Mumps |
0 |
0 |
0 |
|
Pertussis (whooping cough) |
5 |
3 |
5 |
|
Respiratory syncytial virus (RSV) |
311 |
510 |
75 |
|
Salmonellosis |
22 |
14 |
18 |
|
Shigellosis |
1 |
4 |
0 |
|
Streptococcal group A: invasive disease |
6 |
9 |
3 |
|
Streptococcal Group B: invasive (in infants < 90 days) |
1 |
0 |
0 |
|
Streptococcus pneumoniae (pneumococcal invasive disease) |
8 |
7 |
7 |
|
Tuberculosis, active disease |
3 |
0 |
0 |
|
West Nile virus infection |
1 |
0 |
0 |
|
Zika virus infection |
0 |
0 |
0 |
|
COVID-19 |
2,919 |
2,708 |
10,992 |
Data are provisional and subject to change; counts reflect confirmed and probable cases in residents of Mohave County only; Counts are based on date reported to MCDPH, not necessarily date of infection.
**The 5-year median is calculated using counts from this same time period in the years 2019 - 2023. Covid-19 is a 4-yr median